Human diabetic mesenchymal stem cells from peripheral arterial disease patients promote angiogenesis through unique secretome signatures

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Surgery

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.surg.2017.11.018PMID 29395235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Diabetes Mellitus on Critical Limb Ischemia With Below the Knee Disease: Japan Below-the-Knee Artery Treatment Subanalysis

  2020cited by this paper
• Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia

  2017cited by this paper
• Mesenchymal stem cell-conditioned media ameliorate diabetic endothelial dysfunction by improving mitochondrial bioenergetics via the Sirt1/AMPK/PGC-1α pathway.

  2016cited by this paper
• Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties

  2016cited by this paper
• A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization.

  2016cited by this paper
• Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.

  2014cited by this paper
• Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis.

  2014cited by this paper
• Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells

  2013cited by this paper
• Autologous bone marrow mononuclear cells transplant in patients with critical leg ischemia: preliminary clinical results.

  2013cited by this paper
• Very low survival rates after non-traumatic lower limb amputation in a consecutive series: what to do?

  2012cited by this paper
• Treatment of peripheral arterial disease using stem and progenitor cell therapy.

  2011cited by this paper
• Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial.

  2011cited by this paper
• The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design

  2011cited by this paper
• Rapid Endothelial Turnover in Atherosclerosis-Prone Areas Coincides With Stem Cell Repair in Apolipoprotein E–Deficient Mice

  2008cited by this paper
• Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis

  2007cited by this paper
• Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome.

  2007cited by this paper
• Leprdb Diabetic Mouse Bone Marrow Cells Inhibit Skin Wound Vascularization but Promote Wound Healing

  2003cited by this paper
• Angiogenic effect of fibroblast growth factor-1 and vascular endothelial growth factor and their synergism in a novel in vitro quantitative fibrin-based 3-dimensional angiogenesis system.

  2002cited by this paper
• Peripheral arterial disease detection, awareness, and treatment in primary care.

  2001cited by this paper
• Lower extremity amputation for ischemia.

  1978cited by this paper

• Comparison of biological properties of human adipose tissue-derived mesenchymal stem/ stromal cells from healthy and diabetic donors: consequences for cell-based medicinal product development

  2025cites this paper
• Stem Cell Treatments in Preclinical Relevant Stroke Models

  2023cites this paper
• Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Enhance Angiogenesis in Diabetic Rats with Peripheral Artery Disease

  2023cites this paper
• Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell–Derived Microvesicles to Repair the Ischemic Heart

  2021cites this paper
• Exosomes derived from bone marrow mesenchymal stem cells harvested from type two diabetes rats promotes neurorestorative effects after stroke in type two diabetes rats.

  2020cites this paper
• Mesenchymal Stem Cells Decrease M1/M2 Ratio and Alleviate Inflammation to Improve Limb Ischemia in Mice

  2020cites this paper
• Exosomes from Placenta-Derived Mesenchymal Stem Cells Are Involved in Liver Regeneration in Hepatic Failure Induced by Bile Duct Ligation

  2020cites this paper
• Stem Cell Therapy for Lymphedema

  2020cites this paper
• In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia

  2019cites this paper
• Biofabrication of thick vascularized neo-pedicle flaps for reconstructive surgery.

  2019cites this paper
• Quality of cells in autologous cell transplantation for critical limb ischemia.

  2019cites this paper
• Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody

  2018cites this paper
• Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients

  2018cites this paper